Mold Contaminations-Prevention, Investigation, Remediation and Risk Assessment Durham, NC September 17 th & 18 th, 2018

Similar documents
Mold Contamination-Do's and Don'ts

Good Microbiology Laboratory Practices

Auditing Cleanroom Gown Suppliers

Why Disinfectant Qualification Studies Fail

Environmental Monitoring Deficiencies

Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC

Understanding Microbiology Related Data Integrity Issues and Their Causes

Auditing Microbiology Media Suppliers

March 14th, 2014 * San Juan, Puerto Rico Identifying, Preventing, Controlling, Investigating and Remediating Mold Contamination

Strategy for Investigating Microbial Contaminations

Understanding Microbial Control in In-Vitro Diagnostics

Pre-Sterilization Bioburden Failures and Causes

Auditing Cleanroom Gown Suppliers (Europe & Middle East)

Investigating Non-Sterile Product Bioburden Failures

Auditing Cleanroom Gown Suppliers

Microrite, Inc. brings you this unique learning experience in Fungal Identification Simplified E-Workshop; Part of

Key Elements of a Microbial Contamination Control Policy Why and how to write a policy for Microbial Contamination Control

ADVANCED COURSE IN THE IDENTIFICATION OF FUNGI

EU GMP ANNEX 1 DRAFT CLARIFICATION AND IMPACT

Disinfectant Qualification and Cleanroom Disinfection A Step by Step Workshop

Stability Testing for Pre-Clinical and Early Phase Clinical Drug Products

EU GMP ANNEX 1 CHANGES CLARIFICATION AND IMPACT

Considerations when choosing a LIMS System

Disinfectant Qualification Bacteria, Fungi, Viruses and Atypical Organisms A Step by Step Workshop

Microbial Detection Methods and Their Limitations

Environmental Monitoring Requirements and Best Practices for Medical Devices and Drugs New AAMI and ISO EM Reference Documents and Standards

Pharmaceutical Water System Sampling The Why s, Where s, and How s of Doing It Right

Microbial Contamination Testing and Validation Challenges Non-Sterile Products and Raw Materials

Process Validation for FDA Regulated Industries

Understanding GxP (GMP, GCP & GLP) for FDA Regulated Industries

Microrite, Inc. brings you this unique learning experience in Biofilm Basics; Part of Microrite s step-by-step webinar series.

Technology Transfer Critical Points to Consider

Pharmacopoeial Antimicrobial Effectiveness Testing

Filling and Packaging Validation for FDA Regulated Industries

Chemical Sterilization - Alternate Sterilization Methods

Risk Based Incoming Quality Assurance (IQA)

Cleaning-Disinfection-Sterilization of Reusable Medical Devices

CONVENTIONAL AND ALTERNATE STERILIZATION METHODS

Cleaning-Sterilization-Disinfection Validation of Reusable Medical Devices

Supplier Relationship Management

Biofilms in Water Systems - Reasons and Solutions

MICROBIAL LIMIT TESTS FOR RAW MATERIALS AND NON-STERILE PRODUCTS REVIEW-DISCUSSIONS-INTERPRETATIONS

Cleaning Validation-Common Errors

Facility Water Management

Microrite, Inc. brings you this unique learning experience in microbial contamination investigations; part of Microrite s Practical Series Seminars.

Avoiding Microbiological Media Related Failures

OBJECTIONABLE MICROORGANISMS A CHALLENGE OR A DILEMMA

Conducting a Risk Assessment for Non-Sterile Facilities E-Workshop

Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues

Understanding and Testing Compressed Gases

Understanding and Testing Compressed Gases

NEW! Processing of cgmp Controlled Raw Materials

Designing and Sustaining New and Existing Product Stability Testing Program

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

When the FDA comes knocking, will your inspection be a success? YES

Analytical Method Validation

Disinfectant Qualification A Multifaceted Study

Marriot, Irvine, CA - Speaker List and Abstracts

Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)

Cleaning Validation in Active Pharmaceutical Ingredient Manufacturing Plants

SOPs for FDA-Regulated Industry Best Practices to Withstand FDA Expectations

PDA Bioburden and Biofilm Workshop

INTEGRATED MARKETING COMMUNICATIONS FOR ANNUAL GIVING. Learn how to develop consistent messaging across all your annual giving communications.

Century Extrusion presents. Twin-Screw Extrusion Seminar September 29-30, 2009 Seminar Leader: Adam Dreiblatt Akron Polymer Training Center Akron, OH

SPEAKER WHY YOU SHOULD ATTEND. One and a Half Day In-Person Seminar: Location: Los Angeles, CA May 24-25, 2018

Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)

ONE DAY EVENT. Learn effective skills and practical solutions for successful leadership.

SUCCESS Elevating Health Center. Operations, Level III (POM III) Operations Management Seminar, Level III GOOD DECISION MAKING

CONTROLLING DRINKING WATER QUALITY IN THE DISTRIBUTION SYSTEM

LeadingAge North Carolina s 57 th Annual Meeting and Spring Conference May 13-16, 2013

When the FDA comes knocking, will your inspection be a success? YES

LeadingAge North Carolina s 58 th Annual Meeting and Spring Conference May 12-15, 2014

A Practical Introduction to Sterile Manufacturing 25th September 2018 Nailcote Hall Hotel Warwickshire

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

2017 SWMESA Conference

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION

Bring this workshop to your location: For more information, contact PharmaEd Resources at (217) PharmaED

MEASURING THE ROI OF INTEGRATED MARKETING AND BRANDING INITIATIVES

MEDICAL DEVICE QUALITY & COMPLIANCE Institute 2013

RUNNING A MEANINGFUL SENIOR CAMPAIGN

ENSURING PCI DSS COMPLIANCE IN YOUR ADVANCEMENT SHOP. Is your shop maintaining PCI compliance in all of your efforts?

CLEANING & SANITATION IN FOOD PLANTS

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

a n d B i o s a fety C o n s i d e ra t i o n s

Stability Studies for Pharmaceutical Products (API and finished products)

Process Validation for Active Pharmaceutical Ingredients (API)

OSHA 10-Hour AND OSHA 30-Hour General Industry Voluntary Compliance Courses

Conference Sponsorship & Exhibit Opportunities

Conference Sponsorship & Exhibit Opportunities

Service Managers Training Program

EFFECTIVE PROCESS VALIDATION NUSAGE PharmEng Pharmaceutical and Biotechnology Training Program Copyright 2014 NUSAGE-PharmEng.

SELF-PACED TRAINING. Are you properly leveraging your annual giving data?

SPONSORSHIP & EXHIBITION 2019

Service Managers Training Program

PROJECT MANAGEMENT FOR ENGINEERS

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program COMPUTERIZED SYSTEM VALIDATION

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

MAKING PROPERTIES AND PROFITS

Transcription:

Mold Contaminations-Prevention, Investigation, Remediation and Risk Assessment Durham, NC September 17 th & 18 th, 2018 In recent years Mold Contaminations and Recalls have been a focus of attention for the FDA. The wave of mold related inspections and recalls are in response to a deadly fungal meningitis outbreak linked to contaminated steroids from a now infamous compounding pharmacy and a wave of high profile recalls. A risk-based approach to mold is required in order to prevent a catastrophic outcome There is no one solution for preventing, controlling and remediating mold contaminations. The same mold may be detrimental in one product but may have no clinical implication in another. Understanding mold, its proliferation methods and its clinical relevance is the solution. The key is not to panic at the first sight of mold. Environmental monitoring programs which are not risk based rarely track mold thus prevention cannot be practiced. Disinfection is misunderstood in relation to mold proliferation, hence disinfection programs may not kill mold and conducting efficacy studies does not provide holistic solutions. Many times facility design, maintenance and airflow patterns are not adequate and mold may spread within the cleanroom or barrier system due to these deficiencies. A product passing <USP> antimicrobial efficacy test does not guarantee that no mold will grow in the product as preservatives/antimicrobials are tested against easy to control mold. While non-sterile production facilities do not require stringent environmental controls, many mold species are still detrimental in certain non-sterile products. Mold proliferation, prevention and control are not understood because there is a gap in mycological expertise within the pharmaceutical industry. Microrite invites you to attend this never before offered intensive workshop. A mycologist who has been conducting mold contamination investigations for over 25 years teaches this course. Which industries does this workshop apply to? Pharmaceuticals, Biotechnology, Medical Device, and In Vitro Diagnostics, Nutraceuticals and Pharmacies Who will benefit? QC Microbiologists, Manufacturing, Quality Assurance, Validation, Facilities and Training

Day 1 Understanding Mold (Hands-On Exercise) Understand mold classes, sporulation patterns and how easy to kill mold can switch its proliferation method where the spores are impossible to eradicate. This will be a hands on exercise using fungal reference texts and images This exercise will allow attendees to understand that no matter what method you use, you may not always have the correct identification. Learn about the sources of various cleanroom mold isolates and develop a prevention plan Understand where and how these mold can proliferate in your facility Case studies where extensive investigations and CAPAs have led to little or no remediation Discussion on FDA 483s related to mold contaminations Mold Myths and Facts (Classroom Discussion) Myths about disinfection and disinfectant qualification related to mold removal Understanding the fungicidal activity of various disinfectants used in the industry How fungicidal label claims are established and why they could be misleading Dispelling myths about resistance of mold to disinfectants-some mold is hard to kill Common errors in disinfectant efficacy testing that gives false confidence in mold kill Cleaning practices that actually encourage mold growth Contact time myth understand that disinfectant activity does not stop at 10 minutes Antimicrobial/Preservative efficacy testing deficiencies-understand the type of mold tested for efficacy vs other mold types found in cleanrooms

Day 2 Investigating Mold Contaminations (Classroom Discussion) Often the risk of mold contamination is not addressed until contamination has happened! Understand how mold gets into your facility and how it can grow in the facility and in process materials. This can assist a company to comprehend possible mold contamination of the product. Occasionally mold contamination leads to major facility and process design changes after it has made its presence known in the cleanroom in large quantities or has ended up in the product. Understand why investigating and managing mold contamination can be difficult without proper knowledge of mold and controlled environments Points to consider when investigating mold contamination o Facilities o Materials o Raw materials o Process o Product o Laboratory environment and equipment-a common cause of mold related failures o Growth media quality and storage-a common cause of false positive mold results o Cleaning supplies and cleaning procedures Why excessive cleaning and disinfection or fogging is not the solution when it comes to cleanroom contamination by mold Clinical Relevance of Objectionable Mold (Classroom Discussion) Learn about what mold is objectionable via which mode of administration Mold Infections of the central nervous system Systemic mold infections Mold infections via nasal and inhalation pathway Cutaneous and sub-cutaneous mold infections Vaginal and rectal mold infections Oral mold infections Nosocomial mold infections Growth of mold infections over years Guidelines on how to assess risk of mold in your product Understanding the level of risk and making changes to remediate the situation

AGENDA September 17 th & 18 th 2018 North Carolina Biotechnology Center Hamner Conference Center- Congressional Room 15 TW Alexander Dr, Durham, NC 27710 Day 1 Agenda Registration and fast Understanding Mold- Hands on Exercise Understanding Mold- Hands on Exercise (cont.) Lunch Mold Myths and Facts- Classroom Discussion Mold Myths and Facts- Classroom Discussion (cont.) Questions and Answers Day 2 Agenda fast Investigating Mold Contamination- Classroom Discussion Investigating Mold Contamination- Classroom Discussion (cont.) Lunch Clinical Relevance of Objectionable Mold- Classroom Discussion Clinical Relevance of Objectionable Mold- Classroom Discussion (cont.) Questions and Answers and discussions 8.00 AM to 8.30 AM 8.30 AM to 10.00 AM 10.00 AM to 10.15 AM 10.30 AM to 12.00 PM 12.00 PM to 1.00 PM 1.00 PM to 3.00 PM 3.00 PM to 3.15 PM 3.15 PM to 4.15 PM 4.15 PM to 5.00 PM 8.00 AM to 8.30 AM 8.30 AM to 10.00 AM 10.00 AM to 10.15 AM 10.30 AM to 12.00 PM 12.00 PM to 1.00 PM 1.00 PM to 3.00 PM 3.00 PM to 3.15 PM 3.15 PM to 4.15 PM 4.15 PM to 5.00 PM Hotel Recommendations: *Microrite does not have a room block at any hotel. Please choose what you feel comfortable with. Airport: Raleigh-Durham International Airport (RDU) Parking: The Hamner Conference Center provides free parking a short (less than ½ block) walk from the building.

REGISTRATION INFORMATION Personal Information of One Registrant Last Name: Mr. Ms. Dr. First Name: Job Title: Organization: Mailing Address: Telephone: Email: Fee: $1800.00 per attendee (Includes 2 day workshop fee, breakfast, lunch, break, and course material) Additional Attendees Method of Payment: Credit Card and Check payments only. Attendees can register and make payments on Microrite s website-www.microrite.com or complete this form and fax to 408-445-1236. Check payments must be cleared before the workshop date. If you have any questions regarding payment methods feel free to contact Microrite at 408-445-0507 or send your enquiry to labraham@microrite.com. Confirmation of registration will be sent via email. For credit card payment on website, a payment receipt will be considered as confirmation of registration. For credit card information faxed to Microrite an email confirmation will be sent with a copy of payment receipt. Please call 408-445-0507 in due time if confirmation is not received after payment. Workshop cancellation must be received 15 business days prior to the workshop less a 10% service fee, cancellation requests will be accepted via email only. The organizations primary contact or credit card holder must make all refund requests. Refunds will be credited to the original credit card used to purchase the workshop..

PAYMENT INFORMATION Choose One (Place X) VISA Master Card American Express Card Holder s Name Address of Card Holder: Enter firm address for corporate card or personal address for personal card Street: City/State: Zip Code: Country: Contact Ph No & Email: Card Number: Expiration(Month/Year): Amount (US Dollars): Signature: Name of Attendee(s) Referred by: Kindly note the name of the company or person that referred you to this workshop. We would like to thank them..

About the Presenter Ziva Abraham is the President and Founder of Microrite, Inc., a California based consulting firm providing consulting and training services to pharmaceuticals, biotechnology, medical devices and in vitro diagnostics in the areas of quality assurance, quality control, microbiology, and validation. Ziva has over 25 years of academic, research, clinical and industrial experience in microbiology, and quality assurance. Ziva has received her Master s Degree in microbiology with a focus on Mycology and has conducted research on developing microbial Insecticides using entomogenous bacteria and fungi for her PhD degree. Her career also includes founding and managing clinical laboratories for Maccabi Medical in Israel. She has trained personnel from various industries in microbiology techniques and methods. She uses her extensive experience to teach why assessing risk of microbial contamination should be in the forefront of any company that has products for human/veterinary use. Her experience in clinical laboratories has provided her with the framework to understand the effects of microbial contamination in products from a patient safety perspective. Company Microrite s goal is to provide practical solutions through consulting and training Consulting Services Microrite is a San Jose, CA based Consulting Company helping Pharmaceuticals, Biotechnology, Medical Devices, In-Vitro Diagnostics and Combination products in the areas of Quality Assurance, Microbiology, Process Development, Process Validation, Facility and Utility Validation Visit www.microrite.com to learn more about us